AirSupra

Indicated For

Asthma treatment and prevention

About This Medication

# AZ&Me Patient Guide: How to Get AirSupra (albuterol/budesonide) at Low or No Cost ## About AirSupra and Why This Program Matters AirSupra (albuterol/budesonide) is a prescription inhaler approved by the FDA for the as-needed treatment and prevention of bronchospasm in adults with asthma. It combines two active ingredients: albuterol, a short-acting beta-agonist (SABA) that quickly relaxes airway muscles to relieve sudden breathing difficulties, and budesonide, an inhaled corticosteroid (ICS) that reduces inflammation in the lungs to help prevent future attacks. Unlike traditional rescue inhalers that only provide quick relief, AirSupra offers both immediate relief and anti-inflammatory benefits in one convenient dose, potentially reducing the need for separate maintenance therapy during asthma flares. Asthma affects millions of Americans, and the cost of inhalers like AirSupra—often over $600 per inhaler without insurance—can be a major barrier to consistent treatment. Poor adherence due to cost leads to more emergency room visits, hospitalizations, and reduced quality of life. That's where AstraZeneca's AZ&Me Prescription Savings Program comes in. This patient assistance program (PAP) helps eligible individuals access AirSupra at little or no cost, ensuring you can breathe easier without financial stress. AZ&Me covers many AstraZeneca medications, including AirSupra, and is designed for those who struggle to afford their prescriptions. ## Who Qualifies for AZ&Me? AZ&Me is primarily for patients who are uninsured or underinsured and meet certain financial criteria. While exact income thresholds aren't publicly detailed in all resources (they can vary and are often assessed case-by-case), the program generally targets those at or below a percentage of the Federal Poverty Level (FPL), typically around 400-500% FPL, though this should be confirmed during application. It's open to U.S. residents, including those with Medicare Part D or Medicaid who face high out-of-pocket costs. Key eligibility factors include: - **Residency**: Must live in the U.S. or its territories. - **Age**: Available to adults and children (specifics depend on the medication). - **Insurance Status**: Best suited for uninsured patients or those with government insurance who can't afford copays. - **Income**: Household income is evaluated; no strict public cutoffs, but lower-income households are prioritized. ### Income Eligibility Breakdown Since precise thresholds aren't specified, here's a general guide based on common PAP standards. Always verify with AZ&Me as guidelines update annually. The table below uses 2026 Federal Poverty Level (FPL) estimates for context (actual FPL is published yearly by HHS). | Household Size | Estimated Max Income (400% FPL) | Estimated Max Income (500% FPL) | Notes | |---------------|-------------------------------|-------------------------------|-------| | 1 (Individual) | $60,000 | $75,000 | Case-by-case review | | 2 (Couple) | $81,000 | $101,000 | Includes dependents | | 3 | $102,000 | $127,000 | Household income only | | 4 | $123,000 | $154,000 | Add ~$21,000 per additional person for 400% | *Notes*: These are illustrative; AZ&Me may use a different FPL multiplier or asset tests. Provide proof like tax returns or pay stubs. ## Insurance Requirements AZ&Me is available for: - **Uninsured patients**: No private or government coverage. - **Medicare Part D or Medicaid patients**: If you hit the coverage gap (donut hole) or have unaffordable copays. It's **not** for those with commercial insurance that covers AirSupra adequately. If privately insured, explore your plan's copay cards or savings programs first. AZ&Me bridges the gap for vulnerable populations, complying with anti-kickback laws by excluding well-insured individuals. ## Step-by-Step Application Process AZ&Me offers multiple application methods for convenience: 1. **Phone**: Call (866) 480-0030 (Mon-Fri, 8 AM-8 PM ET). A representative guides you; have your doctor's info ready. 2. **Online**: Visit azandme.com (search for AirSupra), download the form, and submit digitally or by mail. 3. **Mail/Fax**: Print the application from the website, complete with prescriber signature, and send to the address provided. 4. **Doctor's Office**: Many providers submit on your behalf via e-application. **Required Documents** (minimal list): - Proof of income (W-2, 1040, pay stubs). - Proof of residency (utility bill, ID). - Pharmacy info. - Prescriber's signed application. **Steps**: 1. Discuss AirSupra with your doctor; get a prescription. 2. Gather documents. 3. Apply via phone/online/mail. 4. Receive approval/denial notice (typically 2-4 weeks). 5. If approved, medication ships free to your pharmacy or home. ## Timeline and Delivery Processing takes 1-4 weeks after submission. Urgent cases may qualify for expedited review—mention at application. Once approved, AirSupra is delivered free via mail or to your pharmacy. Supply duration: Often 12 months, with reapplication needed annually or per refill cycle. Track status by calling (866) 480-0030. ## Alternatives if Denied or Ineligible - **Copay Savings Cards**: AstraZeneca offers AirSupra savings cards for commercially insured (up to $200-300 off). - **Other PAPs**: NeedyMeds.org or RxAssist.org list generics/alternatives like Symbicort (budesonide/formoterol). - **State Programs**: Check your state's pharmaceutical assistance. - **Generic Options**: No exact generic for AirSupra yet; consider albuterol HFA + separate ICS. - **Patient Access Network (PAN) Foundation**: Grants for copays. - **GoodRx/Walgreens discounts**: Up to 80% off retail. Shop around pharmacies for best prices. ## Disclaimer This guide is for informational purposes only and based on publicly available data as of 2026. Eligibility, terms, and availability can change; always contact AZ&Me at (866) 480-0030 or azandme.com for current details. Not medical advice—consult your healthcare provider. AstraZeneca reserves the right to modify or end the program. Word count: 1024.

Program information last verified: March 30, 2026